Maria Martinez - Naturhouse Health Director of Investor Relations
| NTH Stock | EUR 1.68 0.01 0.59% |
Director
Ms. Maria Pardo Martinez serves as Director of Investor Relations at Naturhouse Health, S.A. She began her career as a Corporationrationrate Finance consultant at PricewaterhouseCoopers and later worked as an Equity Analyst at Eurosafei and Bankinter. From 2007 to 2014, she worked as Director of Investor Relations, first at Eurocofin and then at Tinkle. She was also an Associate Professor on the International MBA course at Universidad San Pablo CEU and wrote the prologue to the book Ganar la confianza de los accionistas by NYU professor Baruch Lev. She has a degree in Economics and Business from CUNEF and a Masters degree in Tax and Fiscal Law from the Centro de Estudios Financieros.
| Professional Marks | MBA |
| Phone | 34 914 32 39 53 |
| Web | https://www.naturhouse.com |
Maria Martinez Latest Insider Activity
Tracking and analyzing the buying and selling activities of Maria Martinez against Naturhouse Health stock is an integral part of due diligence when investing in Naturhouse Health. Maria Martinez insider activity provides valuable insight into whether Naturhouse Health is net buyers or sellers over its current business cycle. Note, Naturhouse Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Naturhouse Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Maria Martinez over six months ago Acquisition by Maria Martinez of 4358 shares of JJill subject to Rule 16b-3 | ||
Maria Martinez over six months ago Disposition of tradable shares by Maria Martinez of JJill subject to Rule 16b-3 |
Naturhouse Health Management Efficiency
The company has return on total asset (ROA) of 0.188 % which means that it generated a profit of $0.188 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3758 %, meaning that it generated $0.3758 on every $100 dollars invested by stockholders. Naturhouse Health's management efficiency ratios could be used to measure how well Naturhouse Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 13 records | DIRECTOR Age | ||
| John Reed | Caixabank SA | 80 | |
| Maria Verges | Caixabank SA | 55 | |
| Ignacio Velasco | Caixabank SA | 68 | |
| Koro Unsain | Caixabank SA | 62 | |
| Matthias Bullach | Caixabank SA | 47 | |
| Natalia Gomez | Caixabank SA | 55 | |
| Jose Masia | Caixabank SA | 77 | |
| Jorge Curiel | Caixabank SA | N/A | |
| Javier Riera | Caixabank SA | 61 | |
| Maria Gistau | Caixabank SA | 59 | |
| Eduardo Irazu | Caixabank SA | 63 | |
| Maria Boncompte | Caixabank SA | 62 | |
| Francesc Torrents | Caixabank SA | 64 | |
Management Performance
| Return On Equity | 0.38 | |||
| Return On Asset | 0.19 |
Naturhouse Health Leadership Team
Elected by the shareholders, the Naturhouse Health's board of directors comprises two types of representatives: Naturhouse Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Naturhouse. The board's role is to monitor Naturhouse Health's management team and ensure that shareholders' interests are well served. Naturhouse Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Naturhouse Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kilian Rodriguez, Executive Vice Chairman of the Board | ||
| Rafael Barquero, Director | ||
| Manuel Perez, Chief Officer | ||
| Maria Martinez, Director of Investor Relations | ||
| Juan Welham, Chief International Officer | ||
| Alfonso Bastarreche, Non-Member Secretary | ||
| Marta Salmones, Vice Secretary | ||
| Mario Guerra, Head Audit | ||
| Olivier Roques, General Manager, France & Belgium | ||
| Ignacio Marine, Independent Director | ||
| Frdric Julien, Managing Belgium | ||
| Vanesa Rodriguez, Executive Vice Chairman of the Board | ||
| Felix Fernandez, Executive Chairman of the Board, Chief Executive Officer | ||
| Rafaello Pellegrini, General Director - Italy | ||
| Jose Gimeno, Director of Digital Sales | ||
| Hugo Pinazo, Chief Financial Officer | ||
| Pedro Iniesta, Independent Director | ||
| Jose Rios, Independent Director |
Naturhouse Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Naturhouse Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.38 | |||
| Return On Asset | 0.19 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 80.81 M | |||
| Shares Outstanding | 59.95 M | |||
| Shares Owned By Insiders | 77.77 % | |||
| Shares Owned By Institutions | 1.13 % | |||
| Price To Earning | 12.05 X | |||
| Price To Book | 3.21 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Naturhouse Stock
Naturhouse Health financial ratios help investors to determine whether Naturhouse Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Naturhouse with respect to the benefits of owning Naturhouse Health security.